The menopause market is a multi-billion opportunity that is gaining traction with digital health companies offering innovative solutions to help women manage their symptoms and provide treatment and support. In Vivo spoke with three female founders and entrepreneurs, as well as a partner at Lux Capital and the clinical lead of ORCHA, about this niche market.
Menopause is a $600bn market opportunity that remains largely untapped, according to the Female Founders Fund. But a growing field of digital health solutions including telemedicine, digital therapeutics and women’s health apps, are striving to address this growing market.
With an estimated 1.1 billion women worldwide being postmenopausal by 2025, innovators and investors are starting to pay attention to...
Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.
In a challenging funding environment for biopharma, strategic dealmaking has become a critical growth engine. In Vivo explores what it truly takes to navigate high-stakes acquisitions and partnerships, drawing on insights from seasoned industry leaders.
While the adoption of most favored nation drug pricing in the US stands to affect Japanese biopharma firms now heavily reliant on this market, it might also present an opportunity for pricing and policy reforms at home.
